Drug Shortage Report for SEPTA-CITALOPRAM
| Report ID | 65937 |
| Drug Identification Number | 02355272 |
| Brand name | SEPTA-CITALOPRAM |
| Common or Proper name | Citalopram Hydrobromide |
| Company Name | SEPTA PHARMACEUTICALS INC |
| Market Status | DORMANT |
| Active Ingredient(s) | CITALOPRAM |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100s & 500s |
| ATC code | N06AB |
| ATC description | ANTIDEPRESSANTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2018-11-05 |
| Estimated end date | 2018-12-14 |
| Actual end date | 2019-01-17 |
| Shortage status | Resolved |
| Updated date | 2019-01-22 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7035 MAXWELL ROAD, UNIT # 2 MISSISSAUGA, ONTARIO CANADA L5S 1R5 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2019-01-22 | French | Compare |
| v4 | 2019-01-22 | English | Compare |
| v3 | 2018-11-06 | English | Compare |
| v2 | 2018-10-31 | French | Compare |
| v1 | 2018-10-31 | English | Compare |
Showing 1 to 5 of 5